share_log

康方生物：翌日披露報表

AKESO: Next Day Disclosure Return

香港交易所 ·  Mar 28 08:43
Summary by Moomoo AI
康方生物科技(開曼)有限公司於2024年3月28日根據一般授權完成配售新股份，並於同日向香港聯合交易所有限公司提交了翌日披露報表。該公司在2024年3月21日與2024年3月28日的公告中披露了配售新股份的詳情。此次發行的股份數目為24,800,000股，佔發行前已發行股份的2.95%，每股發行價為HKD 47.65，較上一個營業日的收市價HKD 46.65高出2.14%。發行後，公司的已發行股本從841,057,176股增加至865,857,176股。公司確認已收取全部款項，並已履行所有上市規則要求的條件。
康方生物科技(開曼)有限公司於2024年3月28日根據一般授權完成配售新股份，並於同日向香港聯合交易所有限公司提交了翌日披露報表。該公司在2024年3月21日與2024年3月28日的公告中披露了配售新股份的詳情。此次發行的股份數目為24,800,000股，佔發行前已發行股份的2.95%，每股發行價為HKD 47.65，較上一個營業日的收市價HKD 46.65高出2.14%。發行後，公司的已發行股本從841,057,176股增加至865,857,176股。公司確認已收取全部款項，並已履行所有上市規則要求的條件。
Kangfang Biotechnology (Cayman) Limited completed the distribution of new shares under general mandate on 28 March 2024 and filed the next day's disclosure report with the Hong Kong Stock Exchange Limited on the same day. The company disclosed details of the distribution of new shares in its announcements dated March 21, 2024 and March 28, 2024. The number of shares issued was 24,800,000 shares, representing 2.95% of the shares issued prior to issue. The issue price was HKD 47.65 per share, up 2.14% from the previous business day's closing price of HKD 46.65. After the issuance, the issued share capital of the company increased from 841,057,176 shares to 865,857,176 shares. The Company confirms that all payments have been received and that all the conditions required by the Listing Rules have been met.
Kangfang Biotechnology (Cayman) Limited completed the distribution of new shares under general mandate on 28 March 2024 and filed the next day's disclosure report with the Hong Kong Stock Exchange Limited on the same day. The company disclosed details of the distribution of new shares in its announcements dated March 21, 2024 and March 28, 2024. The number of shares issued was 24,800,000 shares, representing 2.95% of the shares issued prior to issue. The issue price was HKD 47.65 per share, up 2.14% from the previous business day's closing price of HKD 46.65. After the issuance, the issued share capital of the company increased from 841,057,176 shares to 865,857,176 shares. The Company confirms that all payments have been received and that all the conditions required by the Listing Rules have been met.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more